Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1527

1.

A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.

Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD, Mongin SJ, Cordes JE, Engelhard D.

J Natl Cancer Inst. 2004 May 19;96(10):770-80.

PMID:
15150305
2.

Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.

Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, DiPlacido R, Ferrari A, Ferraris R, Ferrero F, Fracchia M, Gasperoni S, Malfitana G, Recchia S, Risio M, Rizzetto M, Saracco G, Spandre M, Turco D, Turco P, Zappa M; SCORE2 Working Group-Italy..

J Natl Cancer Inst. 2005 Mar 2;97(5):347-57.

PMID:
15741571
3.

Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment.

Jones RM, Mongin SJ, Lazovich D, Church TR, Yeazel MW.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):777-84. doi: 10.1158/1055-9965.EPI-07-0441.

4.

Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.

Partin MR, Grill J, Noorbaloochi S, Powell AA, Burgess DJ, Vernon SW, Halek K, Griffin JM, van Ryn M, Fisher DA.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):768-76. doi: 10.1158/1055-9965.EPI-07-0759.

5.

Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings.

Myers RE, Turner B, Weinberg D, Hauck WW, Hyslop T, Brigham T, Rothermel T, Grana J, Schlackman N.

Prev Med. 2001 Oct;33(4):249-60.

PMID:
11570828
6.

Reliability and validity of a questionnaire to measure colorectal cancer screening behaviors: does mode of survey administration matter?

Vernon SW, Tiro JA, Vojvodic RW, Coan S, Diamond PM, Greisinger A, Fernandez ME.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):758-67. doi: 10.1158/1055-9965.EPI-07-2855.

7.

Validation of self-reported history of colorectal cancer screening.

Khoja S, McGregor SE, Hilsden RJ.

Can Fam Physician. 2007 Jul;53(7):1192-7.

8.

Measuring the quality of colorectal cancer screening: the importance of follow-up.

Etzioni DA, Yano EM, Rubenstein LV, Lee ML, Ko CY, Brook RH, Parkerton PH, Asch SM.

Dis Colon Rectum. 2006 Jul;49(7):1002-10.

PMID:
16673056
9.
10.

Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV.

J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70.

PMID:
17895475
11.

Colorectal cancer test use--Maryland, 2002-2006.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2007 Sep 14;56(36):932-6.

12.

Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.

Carlos RC, Fendrick AM, Abrahamse PH, Dong Q, Patterson SK, Bernstein SJ.

Womens Health Issues. 2005 Nov-Dec;15(6):249-57.

PMID:
16325138
13.

Cancer screening before and after switching to a high-deductible health plan.

Wharam JF, Galbraith AA, Kleinman KP, Soumerai SB, Ross-Degnan D, Landon BE.

Ann Intern Med. 2008 May 6;148(9):647-55.

PMID:
18458277
14.

Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.

Mandel JS, Church TR, Ederer F, Bond JH.

J Natl Cancer Inst. 1999 Mar 3;91(5):434-7.

PMID:
10070942
16.

Australian general practitioners' views and use of colorectal cancer screening tests.

Sladden MJ, Ward JE.

Med J Aust. 1999 Feb 1;170(3):110-3.

PMID:
10065121
17.

Utilization of colorectal cancer screening tests: a 1997 survey of Massachusetts internists.

Schroy PC 3rd, Geller AC, Crosier Wood M, Page M, Sutherland L, Holm LJ, Heeren T.

Prev Med. 2001 Nov;33(5):381-91.

PMID:
11676578
18.

A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer.

Schoen RE, Weissfeld JL, Trauth JM, Ling BS, Hayran M.

Am J Gastroenterol. 2002 Feb;97(2):446-51.

PMID:
11866286
19.

[Randomized controlled trial of sequence mass screening program for colorectal cancer].

Liu X, Zheng S, Chen K, Ma X, Zhou L, Yu H, Yao K, Chen K, Cai S, Zhang S.

Zhonghua Liu Xing Bing Xue Za Zhi. 2000 Dec;21(6):430-3. Chinese.

PMID:
11860828
20.

Accuracy of self-reports of fecal occult blood tests and test results among individuals in the carpentry trade.

Lipkus IM, Samsa GP, Dement J, Skinner CS, Green LS, Pompeii L, Ransohoff DF.

Prev Med. 2003 Nov;37(5):513-9.

PMID:
14572436

Supplemental Content

Support Center